Estradiol and progeterone
DrugEstradiol and progesterone
Other names: Estradiol and progesterone
NCT Number: NCT01943812
The aim of this study is to compare two FET protocols by modifying the substituted FET cycle in order to maintain a higher ongoing positive pregnancy rate and thus reduce the early pregnancy loss.
Hypothesis: adding GnRH-agonist to the substituted cycle in FET treatment reduces the early pregnancy loss.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Phase 4
IVF syd, Fredericia, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Estradiol and progesterone
Other names: Estradiol and progesterone
Time frame: Primary outcome is avaible after 12th week of gestational.
Time frame: 14 days after embryo transfer.
Time frame: 7th week of gestation
Peter Humaidan
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05322252
Abortion, Second Trimester, Death
St Louis, Missouri, United States
View Trial DetailsNCT05701137
Mental Disorders, PTSD
Barcelona, Spain
View Trial DetailsNCT06493305
Acute Pain, Neurologic Manifestations
Sanliurfa, Turkey (Türkiye)
View Trial DetailsNCT05636553
Pregnancy Loss, Pregnancy Related
Sydney, New South Wales, Australia
View Trial Details